Vanguard Personalized Indexing Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,841	Closed	-$928K	–	1006
2021 Q1	$928K	Buy	7,841 +3,414	+77%	+$404K	0.14%	162
2020 Q4	$523K	Buy	4,427 +1,398	+46%	+$162K	0.11%	209
2020 Q3	$337K	Buy	3,029 +508	+20%	+$54.5K	0.09%	262
2020 Q2	$258K	Sell	2,521 -4,710	-65%	-$504K	0.12%	226
2020 Q1	$780K	Buy	+7,231	New	+$831K	0.45%	58

Vanguard Personalized Indexing Management's CBPO Position: Q2 2021 in Review

Vanguard Personalized Indexing Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 7,841 shares — an estimated $928K sold.

Vanguard Personalized Indexing Management first reported a position in CBPO in Q1 2020 and held it in 5 quarters. The position peaked at $928K in Q1 2021. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

Vanguard Personalized Indexing Management reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
Vanguard Personalized Indexing Management sold 7,841 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $928K.
Vanguard Personalized Indexing Management first reported a position in China Biologic Products Holdings, Inc. in Q1 2020 and held it in 5 quarters.
Vanguard Personalized Indexing Management's China Biologic Products Holdings, Inc. position peaked at $928K in Q1 2021.
0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2021, filed 21 Jul 2021.